Investigational Stem cell treatment for congestive heart failure patients
Thomas Heywood, M.D.
This study will compare an investigational stem cell procedure to a sham procedure. Patients will be required to have 2-3 days of screening, stay overnight in the hospital for the procedure, and attend follow-up visits at least every 6 months. Phone call contacts will be done each month.
Have an Ejection Fraction of 40% or less
Have had a hospitalization for heart failure within the last 9 months
Be on diuretics
Be on maximum tolerated heart failure medications
Be NYHA class 2-3
Meet all other eligibility criteria
Have severe COPD
Be unable to walk
Have an aortic valve prosthesis
Have been treated with any active stem cell product
Be in another clinical trial
The goal of this study is to evaluate the safety and effectiveness of the investigational stem cell product for restoring heart muscle function.